Clinical trial

Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric…

NCT00207935 · Children's National Research Institute, Other · Completed

Key facts

NCT number NCT00207935
Title Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population
Official title Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population
Lead sponsor Children's National Research Institute, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Epilepsy, Mental Retardation, Developmental Disabilities
Intervention type Behavioral
Interventions Swallow instruction
Enrollment 20
Start date Aug 1, 2005
Completion Mar 1, 2007
First posted Sep 21, 2005
Last update posted May 5, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies